181 related articles for article (PubMed ID: 35057043)
1. Novel Nanoparticles Based on
Trapani A; Cometa S; De Giglio E; Corbo F; Cassano R; Di Gioia ML; Trombino S; Hossain MN; Di Gioia S; Trapani G; Conese M
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057043
[TBL] [Abstract][Full Text] [Related]
2. Nose-to-brain delivery: A comparative study between carboxymethyl chitosan based conjugates of dopamine.
Di Gioia S; Trapani A; Cassano R; Di Gioia ML; Trombino S; Cellamare S; Bolognino I; Hossain MN; Sanna E; Trapani G; Conese M
Int J Pharm; 2021 Apr; 599():120453. PubMed ID: 33675929
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of novel chitosan-dopamine or chitosan-tyrosine conjugates for potential nose-to-brain delivery.
Cassano R; Trapani A; Di Gioia ML; Mandracchia D; Pellitteri R; Tripodo G; Trombino S; Di Gioia S; Conese M
Int J Pharm; 2020 Nov; 589():119829. PubMed ID: 32877724
[TBL] [Abstract][Full Text] [Related]
4. Carboxymethyl chitosan dopamine conjugates: Synthesis and evaluation for intranasal anti Parkinson therapy.
Di Gioia S; Fracchiolla G; Cometa S; Perna FM; Quivelli AF; Trapani G; Daniello V; Nobile C; Hossain MN; Trapani A; Conese M
Int J Biol Macromol; 2023 Dec; 253(Pt 5):127174. PubMed ID: 37783252
[TBL] [Abstract][Full Text] [Related]
5. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
[TBL] [Abstract][Full Text] [Related]
6. Dopamine-loaded lipid based nanocarriers for intranasal administration of the neurotransmitter: A comparative study.
Trapani A; De Giglio E; Cometa S; Bonifacio MA; Dazzi L; Di Gioia S; Hossain MN; Pellitteri R; Antimisiaris SG; Conese M
Eur J Pharm Biopharm; 2021 Oct; 167():189-200. PubMed ID: 34333085
[TBL] [Abstract][Full Text] [Related]
7. Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.
Pahuja R; Seth K; Shukla A; Shukla RK; Bhatnagar P; Chauhan LK; Saxena PN; Arun J; Chaudhari BP; Patel DK; Singh SP; Shukla R; Khanna VK; Kumar P; Chaturvedi RK; Gupta KC
ACS Nano; 2015 May; 9(5):4850-71. PubMed ID: 25825926
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of plant elicitor daphnetin-carboxymethyl chitosan nanoparticles against Ralstonia solanacearum by activating plant system resistance.
Wang Y; Yang L; Zhou X; Wang Y; Liang Y; Luo B; Dai Y; Wei Z; Li S; He R; Ding W
Int J Biol Macromol; 2023 Jun; 241():124580. PubMed ID: 37100321
[TBL] [Abstract][Full Text] [Related]
9. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery.
Trapani A; De Giglio E; Cafagna D; Denora N; Agrimi G; Cassano T; Gaetani S; Cuomo V; Trapani G
Int J Pharm; 2011 Oct; 419(1-2):296-307. PubMed ID: 21821107
[TBL] [Abstract][Full Text] [Related]
10. Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake.
Musumeci T; Pellitteri R; Spatuzza M; Puglisi G
J Pharm Sci; 2014 Feb; 103(2):628-35. PubMed ID: 24395679
[TBL] [Abstract][Full Text] [Related]
11. Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method.
Md S; Haque S; Fazil M; Kumar M; Baboota S; Sahni JK; Ali J
Expert Opin Drug Deliv; 2014 Jun; 11(6):827-42. PubMed ID: 24655115
[TBL] [Abstract][Full Text] [Related]
12. In vitro investigations on dopamine loaded Solid Lipid Nanoparticles.
Cometa S; Bonifacio MA; Trapani G; Di Gioia S; Dazzi L; De Giglio E; Trapani A
J Pharm Biomed Anal; 2020 Jun; 185():113257. PubMed ID: 32199326
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin loaded magnetic Fe3O4/carboxymethylchitosan nanoparticles as tumor-targeted drug delivery system: Synthesis and in vitro characterization.
Li G; Cao L; Zhou Z; Chen Z; Huang Y; Zhao Y
Colloids Surf B Biointerfaces; 2015 Apr; 128():379-388. PubMed ID: 25779605
[TBL] [Abstract][Full Text] [Related]
14. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
15. Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease.
Tang S; Wang A; Yan X; Chu L; Yang X; Song Y; Sun K; Yu X; Liu R; Wu Z; Xue P
Drug Deliv; 2019 Dec; 26(1):700-707. PubMed ID: 31290705
[TBL] [Abstract][Full Text] [Related]
16. The Trigeminal Pathway Dominates the Nose-to-Brain Transportation of Intact Polymeric Nanoparticles: Evidence from Aggregation-Caused Quenching Probes.
Li Y; Wang C; Zong S; Qi J; Dong X; Zhao W; Wu W; Fu Q; Lu Y; Chen Z
J Biomed Nanotechnol; 2019 Apr; 15(4):686-702. PubMed ID: 30841963
[TBL] [Abstract][Full Text] [Related]
17. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
[TBL] [Abstract][Full Text] [Related]
18. Oxidized Alginate Dopamine Conjugate: In Vitro Characterization for Nose-to-Brain Delivery Application.
Trapani A; Corbo F; Agrimi G; Ditaranto N; Cioffi N; Perna F; Quivelli A; Stefàno E; Lunetti P; Muscella A; Marsigliante S; Cricenti A; Luce M; Mormile C; Cataldo A; Bellucci S
Materials (Basel); 2021 Jun; 14(13):. PubMed ID: 34201634
[TBL] [Abstract][Full Text] [Related]
19. Nose to brain delivery in rats: Effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization.
Bonaccorso A; Musumeci T; Serapide MF; Pellitteri R; Uchegbu IF; Puglisi G
Colloids Surf B Biointerfaces; 2017 Jun; 154():297-306. PubMed ID: 28363190
[TBL] [Abstract][Full Text] [Related]
20. The effect of doxycycline-containing chitosan/carboxymethyl chitosan nanoparticles on NLRP3 inflammasome in periodontal disease.
Xu S; Zhou Q; Jiang Z; Wang Y; Yang K; Qiu X; Ji Q
Carbohydr Polym; 2020 Jun; 237():116163. PubMed ID: 32241426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
